Call us now :08045478739

Send Inquiry

Send Inquiry

Request To Call Back

Viraday Tablets Cipla

Name: Viraday Tablets Cipla
Brand: PARTH IMPEX

Get a Price/Quote

MOQ : 100 Packs

Viraday Tablets Cipla Specification

Life Span
2 years from date of manufacture

Pacakaging (Quantity Per Box)
30 tablets

Origin of Medicine
India

Indication
Treatment of HIV-1 infection

Packaging Type
Plastic bottle

Salt Composition
Tenofovir Disoproxil Fumarate, Emtricitabine, Efavirenz

Brand Name
Viraday

Dosage Form
Oral tablet

Drug Type
Allopathic

Ingredients
Tenofovir Disoproxil Fumarate 300 mg, Emtricitabine 200 mg, Efavirenz 600 mg

Physical Form
Tablets

Function
Antiretroviral therapy for HIV-1 infection

Recommended For
Adults and adolescents over 12 years of age infected with HIV-1

Dosage
As directed by physician, typically one tablet once daily

Dosage Guidelines
Take on an empty stomach, preferably at bedtime

Quantity
30 tablets per bottle

Storage Instructions
Store below 30C in a dry place, protect from light

Special Precaution
Monitor for skin reactions, psychiatric symptoms, and renal function

Administration Route
Oral

Color
Yellow

Manufactured By
Cipla Ltd.

Prescription Required
Yes

Shape
Oval

Contraindication
Not recommended for children below 12 years or patients with known hypersensitivity to any components

Expiry Details
Check label for batch-specific expiry date

Viraday Tablets Cipla Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

Viraday Tablets Cipla About

Viraday Tablets by Cipla Ltd. have garnered favorable reviews for their commanding efficacy as a pivotal antiretroviral therapy. Designed for adults and adolescents over 12, these superb yellow, oval tablets deliver a powerful combination of Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz to manage HIV-1 infection. Prescription is required, and patients are advised to monitor for skin reactions, psychiatric symptoms, and renal function. Each plastic bottle contains 30 tablets. Place your order confidently with assured quality and reliable manufacturing-new stock is regularly available for timely needs.

Application Details and Surface Use for Viraday Tablets Cipla

Viraday Tablets Cipla are administered orally, making them suitable for individuals who require a systemic form of HIV-1 treatment. The site of application is internal, specifically the digestive tract, after swallowing the tablet whole. An extra feature is their precise dosage-one tablet daily, preferably taken on an empty stomach before bedtime, ensures patient convenience and adherence. The bright yellow, oval tablets also feature clear labeling, aiding in proper identification and compliance with treatment protocols.

Export Details and Certifications of Viraday Tablets Cipla

Viraday Tablets Cipla are shipped from leading FOB ports in India, targeting premium international markets across Asia, Africa, Europe, and other continents. All consignments are efficiently handled to guarantee timely delivery and ensure product safety upon arrival. The tablets come with certifications reflecting strict manufacturing standards, including batch-specific expiry details. As a preferred supplier, exporter, and trader, Cipla ensures reliable service and superior quality assurance from order placement to worldwide arrival.

FAQ's of Viraday Tablets Cipla:

Q: How should Viraday Tablets Cipla be administered for best results?

A: Viraday Tablets should be taken orally, once daily on an empty stomach, ideally at bedtime, as directed by your physician to maximize absorption and efficacy.

Q: What special precautions should I take when using Viraday Tablets?

A: Patients should monitor regularly for signs of skin reactions, psychiatric symptoms, and changes in renal function. It is important to follow your healthcare provider's guidance and report any unusual symptoms promptly.

Q: When is Viraday Tablets contraindicated?

A: Viraday Tablets are contraindicated in children below 12 years and individuals who have a known hypersensitivity to any of its components. Always disclose allergies to your physician before starting treatment.

Q: Where is Viraday Tablets Cipla manufactured and exported from?

A: These tablets are manufactured by Cipla Ltd. in India and exported worldwide from top FOB ports in the country, reaching diverse global markets through a robust distribution network.

Q: What are the main benefits of using Viraday Tablets Cipla?

A: Viraday Tablets provide pivotal antiretroviral therapy for HIV-1 infection in adults and adolescents over 12, supporting effective viral management and enhanced patient health when integrated into a prescribed treatment regimen.

Tell us about your requirement